Want to join the conversation?
An analyst from Citi asks on the dynamics of pricing and rebate of biosimilars between $MRK & its partners. Adam Schechter, President said the pricing and rebate is determined by the $MRK and the European team. The company has been successful competing through patients on existing therapy, but have lost many new patient starts, hence a fall YoverY.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!